|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.28 SEK | -0.78% |
|
-5.74% | -39.34% |
ExpreS2ion Biotech Holding AB (publ) reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported sales was SEK 0.923 million compared to SEK 2.57 million a year ago. Revenue was SEK 1.56 million compared to SEK 2.59 million a year ago.
Net loss was SEK 12.85 million compared to SEK 26.31 million a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -39.34% | 6.25M | |
| -2.29% | 89.87B | |
| -3.95% | 37.57B | |
| -13.07% | 32.75B | |
| +63.05% | 26.47B | |
| -22.14% | 14.25B | |
| -7.96% | 12.99B | |
| -9.33% | 11.93B | |
| -46.33% | 10.84B | |
| +5.77% | 9.11B |
EXPRES2ION BIOTECH HOLDING AB 
